1. Home
  2. BNZI vs HOTH Comparison

BNZI vs HOTH Comparison

Compare BNZI & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banzai International Inc.

BNZI

Banzai International Inc.

HOLD

Current Price

$1.15

Market Cap

9.6M

Sector

N/A

ML Signal

HOLD

Logo Hoth Therapeutics Inc.

HOTH

Hoth Therapeutics Inc.

HOLD

Current Price

$1.18

Market Cap

18.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNZI
HOTH
Founded
2016
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6M
18.0M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
BNZI
HOTH
Price
$1.15
$1.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$23.00
$4.50
AVG Volume (30 Days)
495.6K
216.5K
Earning Date
11-14-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,650,176.00
N/A
Revenue This Year
$223.24
N/A
Revenue Next Year
$31.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
147.06
N/A
52 Week Low
$1.09
$0.66
52 Week High
$27.00
$3.80

Technical Indicators

Market Signals
Indicator
BNZI
HOTH
Relative Strength Index (RSI) 34.70 44.20
Support Level $1.14 $1.16
Resistance Level $1.37 $1.25
Average True Range (ATR) 0.12 0.06
MACD 0.04 0.01
Stochastic Oscillator 11.76 52.96

Price Performance

Historical Comparison
BNZI
HOTH

About BNZI Banzai International Inc.

Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).

Share on Social Networks: